CN111450316A - Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure - Google Patents
Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure Download PDFInfo
- Publication number
- CN111450316A CN111450316A CN202010144383.5A CN202010144383A CN111450316A CN 111450316 A CN111450316 A CN 111450316A CN 202010144383 A CN202010144383 A CN 202010144383A CN 111450316 A CN111450316 A CN 111450316A
- Authority
- CN
- China
- Prior art keywords
- nanofiber
- yarns
- mineral content
- bone
- mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0092—Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
- D03D15/40—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the structure of the yarns or threads
- D03D15/47—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used characterised by the structure of the yarns or threads multicomponent, e.g. blended yarns or threads
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D3/00—Woven fabrics characterised by their shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/424—Anti-adhesion agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Textile Engineering (AREA)
- Dispersion Chemistry (AREA)
- Mechanical Engineering (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to an integrated bracket for simulating a bone-tendon-bone mineralization to non-mineralization gradient structure, wherein warps are nanofiber yarns with zero mineral content, wefts in the middle of the bracket are nanofiber yarns with zero mineral content, and the wefts in the middle to two ends are sequentially nanofiber yarns with gradually increased mineral content. The integrated bracket for simulating the bone-tendon-bone mineralization-non-mineralization gradient structure constructed by the invention provides an ideal microenvironment for repairing tendon defects, realizes the guidance of tendon tissue regeneration after implantation, promotes tendon-bone healing, and is very suitable for tendon-bone injury repair.
Description
Technical Field
The invention belongs to the field of tendon/ligament scaffolds, and particularly relates to an integrated scaffold for simulating a gradient structure from bone-tendon-bone mineralization to non-mineralization.
Background
The tendon/ligament (T/L) refers to a tough, regularly arranged bundle of connective tissue connecting muscles and bones, transferring strength from muscles to bones, enabling stabilization and movement of joint function, as the tendon has rigidity between muscles and bones, its role is equivalent to elastic cushioning between muscles and bones.T/L injury is mainly caused by frequent stretching under severe impact or low strength, including rupture, tearing, degeneration or inflammation, and has become one of the most common injuries in the human body.
At present, the reconstructed bone tract segment and joint cavity segment between the artificial ligament and the host bone have certain difference in histological characteristics. Ligament prosthesis lacks osteoconductivity, autologous bone can not grow into the artificial ligament effectively, resulting in graft-bone healing disorder and serious bone canal enlargement; at the same time, the adhesion and proliferation of cells are influenced, so that the cells are difficult to self-assemble in joint cavities. The existing artificial ligament can not realize the complicated layered transition structure from mineralized to non-mineralized tissues at the tendon-bone interface, and is difficult to achieve the ideal repairing effect of the tendon-bone interface, thereby influencing the tendon/ligament function.
In view of the above problems, there is a need for an improved structure of the existing artificial tendon/ligament, which has fine adjustment of its components. In recent years, researches prove that the electrospun nanofiber can simulate a filamentous structure of an extracellular matrix of a tissue, has a larger specific surface area, is beneficial to adsorbing more proteins, can provide more adhesion sites for receptors on a cell membrane, promotes adhesion, proliferation and differentiation of cells, regulates a signal path for controlling transcriptional activity and gene expression in the cells, guides directional arrangement of cytoskeletal proteins, and is widely applied to tissue repair scaffolds, particularly tendon/ligament repair. The nano yarn is similar to collagen fiber formed by a plurality of triple-helical structures, and well simulates a nano filamentous structure of tendon extracellular matrix. The three-dimensional scaffold obtained by combining the electrospinning nano yarn technology with the traditional weaving technology can simulate a multilayer structure of a natural tendon/ligament tissue from a nanometer level to a macroscopic level, better simulate the shape of the natural tendon/ligament tissue and promote the regeneration of the tendon tissue.
CN 208481528U discloses a mixed artificial ligament, but the ligament material is only composed of biodegradable and non-degradable parts, and can not simulate the mineralization of a natural tendon-bone combination part to a non-mineralized gradient structure.
Disclosure of Invention
The invention aims to solve the technical problem of providing an integrated bracket for simulating a bone-tendon-bone mineralization to non-mineralization gradient structure, which fills the blank that an artificial tendon/ligament bracket cannot simulate the integrated bracket for simulating the bone-tendon-bone mineralization to the non-mineralization gradient structure.
The integrated bracket is characterized in that the warps are nanofiber yarns (J) with zero mineral content, the wefts in the middle of the bracket are nanofiber yarns (W1) with zero mineral content, and the wefts in the middle to two ends are sequentially nanofiber yarns (W2, W3 and W4) with gradually increased mineral content.
The integrated stent appearance includes, but is not limited to, an elongated shape, a flat shape, a cylinder.
The nanofiber yarn is of a core-spun structure, wherein a core layer is a polymer yarn, an outer layer is an electrospun nanofiber, the nanofiber wraps the polymer yarn to form the nanofiber yarn, and in the nanofiber yarn with zero mineral content, the electrospun nanofiber on the outer layer contains a polymer and an electrospun nanofiber of a natural polymer, but does not contain minerals; in the mineral-loaded nanofiber yarn, the outer layer electrical discharge nanofiber contains minerals, polymers and natural macromolecules.
The polymer yarn is a single yarn with the diameter of 0.03-0.1 mm formed by merging and drafting a plurality of polymer single fibers with the diameter of 20-50 microns.
The polymer line is one or more of polyethylene terephthalate (PET) line, polylactic acid (P L A) line, polycaprolactone (PC L) line, lactic acid-glycolic acid copolymer (P L GA) line and Silk Fibroin (SF) line, the polymer is one or more of lactic acid-caprolactone copolymer (P L C L), polycaprolactone (PC L) and lactic acid-glycolic acid copolymer (P L GA), and the natural polymer is one or more of Silk Fibroin (SF), collagen (CO L) and gelatin.
The mineral is one or more of hydroxyapatite HA, bioactive glass, silicon dioxide, calcium carbonate and calcium phosphate mineral.
Further, the nano-fiber with zero mineral content comprises polymer and natural polymer nano-fiber; wherein, preferably, the polymer comprises one or more of lactic acid-caprolactone copolymer, polycaprolactone and polylactic acid-glycolic acid copolymer; the natural polymer comprises one or more of silk fibroin, collagen and gelatin.
Further, the mineral nanofiber comprises a polymer, a natural polymer and an added mineral blending nanofiber; wherein, preferably, the polymer comprises one or more of lactic acid-caprolactone copolymer, polycaprolactone and polylactic acid-glycolic acid copolymer; the natural polymer comprises one or more of silk fibroin, collagen and gelatin; the mineral is hydroxyapatite, bioactive glass, silicon dioxide, calcium carbonate, or calcium phosphate.
The integrated bracket comprises a mineralized part and a non-mineralized part, wherein the non-mineralized part is positioned in the middle of the bracket, and the mineralized part is positioned at two ends of the bracket.
The integrated bracket can simulate the histological characteristics of the bone tract section and the joint cavity section, and the mineralized part (W2, W3 and W4) has osteoconductivity and accelerates the effective growth of autogenous bones of the bone tract section; the non-mineralised (W1) portion is capable of promoting its automization within the joint cavity. (the mineralized part of the scaffold is W2, W3 and W4; the non-mineralized part is W1; the warp is J containing no mineral substance; J and W1 are the same material and are completely the same, but J and W1 are used for distinguishing the warp from the weft respectively, and can be represented by the same letter)
The length of the integrated bracket is 5-50 mm, the width of the integrated bracket is 5-20 mm, and the length of the non-mineralized part is 5-30 mm; the unilateral mineralization length is 10-20 mm.
The mineralized part is woven by nano fiber yarns with different mineral contents, and the non-mineralized part is woven by nano fiber yarns with zero mineral content.
The length of the support is 5-50 mm, and the width of the support is 5-20 mm.
The support is as follows: the nanofiber yarn with zero mineral content is used as warp yarns, the distance between the two warp yarns is 0.5-2 mm, and 10 warp yarns are adopted for each support; the middle of the bracket uses nanofiber yarns with zero mineral content as wefts, the nanofiber yarns with gradually increased mineral content are sequentially used as wefts from the middle to two sides, the weaving length of each weft is 2-10 mm, and the nanofiber yarns in the warp direction and the weft direction are interwoven to form the bracket.
Further, the nanofiber yarn with zero mineral content is formed by twisting P L C L/SF nanofibers onto a core layer P L A line.
Furthermore, the nanofiber yarn with the mineral content gradient increased comprises P L A-P L C L/SF/HA nanofiber yarn, and the loaded HA content is 5%, 10% and 15%.
The invention discloses a preparation method of an integrated bracket, which comprises the following steps:
(1) respectively preparing polymer-containing and natural polymer blending spinning solutions; the blended spinning solution contains polymers, natural polymers and minerals with different contents;
(2) passing a core layer line through a hollow rotating funnel, then connecting the blended spinning solution obtained in the step (1) to two opposite-spraying spinning heads, respectively applying positive and negative electric fields to the spraying spinning heads, spraying the nanofibers on the middle rotating funnel and the core layer line, twisting the nanofibers to the core layer line by the rotating funnel, and receiving by a receiving roller to obtain nanofiber yarns with zero mineral content and nanofiber yarns loaded with minerals with different content;
(3) the mineral content of the nanofiber yarns is zero, the mineral content of the nanofiber yarns is different, the nanofiber yarns in the warp direction and the weft direction are interwoven by a weaving method, the mineral content of the nanofiber yarns is zero in the weft of the middle of the bracket, the mineral content of the nanofiber yarns gradually increasing from the middle to the two ends of the bracket is sequentially adopted as the weft, and the integrated bracket with the mineralized to non-mineralized gradient structure is obtained.
The preferred mode of the above preparation method is as follows:
the mass fraction of the spinning solution in the step (1) is between 5 and 20 percent. Further, 6%, 8%, 9%, 10.5%, 15%, etc., more preferably 8%.
The mass ratio of the polymer to the natural polymer in the step (1) is 90: 10-10: 90; preferably, the mass ratio of the polymer to the natural macromolecule is 90:10, 80:20, 70:30, 75:25, 60:40, 50:50, 40:60, 25:75, 30:70, 20:80 or 10: 90.
The mass fraction of the added minerals in the blended spinning solution is 0-20%, preferably 5%, 10% and 15%.
The solvent for preparing the spinning solution in the step (1) is one or more of hexafluoroisopropanol, trifluoroethanol, dichloromethane and trifluoroacetic acid.
The specific process of electrostatic spinning in the step (2) is that the spinning solution is added into an injector, then spinning nozzles at the left end and the right end of a rotating funnel are respectively connected, positive and negative high voltage of 8KV is respectively applied, the speed of a propelling pump is 1.2m L/h, the receiving distance is 12cm, the rotating speed of the rotating funnel is 400 r/min, and the receiving roller is 8 r/min.
The invention provides an integrated bracket prepared by the method.
The invention provides an application of the integrated stent as a tendon and ligament stent.
The invention firstly prepares a core-spun nanofiber yarn, a spraying nozzle is respectively added with a positive electric field and a negative electric field, a core layer wire passes through a hollow rotating funnel to be used as a receiving device, after two nozzles spray nanofibers to the rotating funnel in the middle and the core layer wire, the rotating funnel twists the nanofibers to the core layer wire, and a receiving roller receives the nanofibers to obtain the continuous nanofiber yarn. Then, the integrated bracket is prepared by interweaving the nanofiber yarns along the warp direction and the weft direction by a weaving method. The integrated bracket is prepared by adopting nanofiber yarns with zero mineral content as warps, adopting nanofiber yarns with zero mineral content as wefts in the middle part, and sequentially adopting nanofiber yarns with gradually increased mineral content as wefts from the middle part to two ends.
Advantageous effects
(1) The invention provides an integrated bracket for simulating a bone-tendon-bone mineralization to non-mineralization gradient structure, which consists of a mineralization part and a non-mineralization part; the mineralized part has osteoconductivity, promotes the autologous bone of the bone tract section to effectively grow in, and the non-mineralized part guides and promotes the endogenous repair of the tendon, so that the joint cavity is self-formed (as shown in an alizarin red test data figure 8 in the example).
(2) The integrated scaffold for simulating the bone-tendon-bone mineralization-non-mineralization gradient structure provided by the invention has the advantages that the pore size of the scaffold is suitable (the pore size of the scaffold is 40-70 mu m), the problems that the pore size of a nanofiber scaffold is small and cells are difficult to grow in are solved, the three-dimensional cell growing-in capacity is improved, the scaffold is reorganized and fibrillated along with the proliferation and growing of tendon/ligament self tissues, and a community is formed by the scaffold and the human body self tissues, so that a better motion function and motion feeling are provided for a patient.
(3) The polymer and the natural polymer used in the invention are biodegradable materials, can be gradually degraded in a certain period, and are beneficial to the formation of regenerated tendon/ligament tissues. The degradation product can be discharged along with the normal metabolism of the human body, has no side effect on the human body, and achieves the ideal tendon/ligament reconstruction and repair (the used material is degradable material, and has no side effect after in vivo degradation).
(4) The composite material nanofiber yarn is used as the minimum weaving unit, and compared with the single material yarn, the composite material nanofiber can exert the advantages of various repair materials. Meanwhile, the woven structure is finer, the strength is higher, and higher mechanical strength can be provided. (As shown in the SEM pictures, it can be seen that the structure is dense, which results in high mechanical strength.)
(5) The bone-tendon-bone mineralization simulation to non-mineralization gradient structure integrated scaffold provided by the invention can be added with anti-inflammatory and tissue adhesion prevention medicines or growth factors in the preparation process according to clinical requirements, so that the inflammatory reaction is relieved, the tissue adhesion is avoided, and the tendon repair and normal function recovery are promoted.
Drawings
FIG. 1 is a schematic diagram of a process for preparing an electrospun nanofiber yarn;
FIG. 2 is a photograph of an integrated scaffold simulating mineralization of bone-tendon-bone to non-mineralization gradient structure;
fig. 3 is a mic-CT scan picture of a scaffold integrating a gradient structure simulating bone-tendon-bone mineralization to non-mineralization, wherein (a) is a front view, (b) is an oblique view, and (c) is a side view;
FIG. 4 is a scanning electron microscope (a) and a transmission electron microscope (b) of a single nanofiber yarn surface loaded with hydroxyapatite of different contents;
FIG. 5 is a scanning electron microscope image of the non-mineralized portion (PPS-0% HA) and the gradient mineralized portion (PPS-5% HA, PPS-10% HA, PPS-15% HA) of the integrated scaffold;
FIG. 6 is a graph showing water contact angles of portions of the integrated scaffold simulating mineralization of bone-tendon-bone to non-mineralization gradient structure;
FIG. 7 shows the activity of each part of the integrated scaffold simulating the mineralization of bone-tendon-bone to non-mineralization gradient structure on rat bone marrow mesenchymal stem cells (BMSC) at various time points (1 day, 4 days, 7 days);
FIG. 8 shows calcium content expression of each part of the alizarin red quantitative determination integrated scaffold acting on BMSC cells, respectively;
FIG. 9 is a schematic view of an integrated bracket structure of the present invention; wherein (J) is the nano fiber yarn with zero mineral content as warp yarn, (W1, W2, W3 and W4) are the nano fiber yarn with 0%, 5%, 10% and 15% mineral content as weft yarn.
Detailed Description
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Further, it should be understood that various changes or modifications of the present invention may be made by those skilled in the art after reading the teaching of the present invention, and such equivalents may fall within the scope of the present invention as defined in the appended claims.
Example 1
(1) Extracting silk fibroin: weighing 60g of silkworm cocoon, cutting into a plurality of layers, putting the silkworm cocoon into 0.5% sodium bicarbonate water solution, boiling for 30 minutes, repeating twice to remove surface sericin, fully cleaning with deionized water, and airing to obtain the silk fibroin fiber. Placing silk fibroin fiber into CaCl2/H2Dissolving in ternary solvent of O/anhydrous ethanol (molar ratio of 1:8:2) at 70 deg.C for 40 min, dialyzing in dialysis bag with molecular weight cutoff of 14000Da at room temperature for 7 days, filtering to obtain pure silk fibroin aqueous solution, and freeze drying to obtain spongy silk fibroin.
(2) Preparing spinning solution, 0.6g of P (LL A-C L) (75:25) (available from the biological science and technology Co., Ltd.) with molecular weight of about twenty thousand (twenty thousand) and 0.2g of silk fibroin are dissolved in 10m L of hexafluoroisopropanol (available from the fine chemicals Co., Ltd.) to prepare the spinning solution P L C L/SF with mass concentration of 8%.
(3) Preparing a mineral-loaded spinning solution, namely preparing a P L C L/SF spinning solution with the mass concentration of 8% according to the step (2), adding hydroxyapatite (the purity of which is more than or equal to 97% and the particle size of which is less than 100nm) with the mass percentage of 5%, 10% and 15% respectively, and ultrasonically stirring and uniformly dispersing.
(4) Preparing P L A-P L C L/SF (PPS-0% HA) nanofiber yarn by passing a P L A thread (a single thread with the diameter of about 180 microns formed by merging and drafting a plurality of P L A single fibers with the diameter of about 30 microns; from China center of emphasis laboratory of fiber material modification of the university of east China) through a rotating funnel of an electrospinning nanofiber yarn preparing device to be used as a core layer, spraying P L C L/SF spinning solution in the step (2), twisting the P L C L/SF nanofiber onto the P L A thread of the core layer by using the rotating funnel, and collecting continuous PPS-0% HA nanofiber yarn by using a receiving roller.
(5) And (2) preparing the P L A-P L C L0/SF/HA nanofiber yarn, namely, passing a P L1A line through a rotating funnel of electrospinning nanofiber yarn preparation equipment to serve as a core layer, oppositely spraying P L C L/SF/HA spinning solution in the step (3), twisting the P L C L/SF/HA nanofiber onto the P L A line of the core layer by using the rotating funnel, and collecting continuous P L A-P L C L/SF/HA nanofiber yarn by using a receiving roller, wherein the loaded HA content is 5 percent, the loaded HA content is 10 percent, and the 15 percent of yarn is respectively marked as PPS-5 percent HA, PPS-10 percent HA and PPS-15 percent HA.
(6) The process for electrostatic spinning of the nano yarn in the steps (4) to (5) comprises the steps of adding the spinning solution into an injector, then respectively connecting spinning nozzles at the left end and the right end of the yarn, respectively applying positive and negative high voltage of 8KV, respectively, enabling the speed of a propulsion pump to be 1.2m L/h, enabling the receiving distance to be 12cm, enabling the rotating speed of a rotating funnel to be 400 revolutions per minute, and enabling a receiving roller to be 8 revolutions per minute.
Example 2
(1) Preparing the mineralized to non-mineralized gradient structure integrated bracket, namely taking PPS-0% HA nanofiber yarns as warp yarns, taking P L A-P L C L/SF/HA nanofiber yarns loaded with different mineral contents as weft yarns, taking P L A-P L C L/SF yarns with zero mineral content as weft yarns in the middle part of the bracket, taking PPS-5% HA, PPS-10% HA and PPS-15% HA nanofiber yarns as weft yarns in sequence from the middle to two ends, and interweaving the nanofiber yarns in the warp and weft directions by a weaving method to prepare the mineralized to non-mineralized gradient structure integrated bracket.
(2) The weaving process in the step (1) comprises the following steps: on a semi-automatic weaving machine, PPS-0% HA nanofiber yarns are used as warps, the distance between the two warps is 0.5-2 mm, and each support adopts 10 warps; the bracket is characterized in that PPS-0% HA is used as weft yarns in the middle of the bracket, PPS-5% HA, PPS-10% HA and PPS-15% HA are used as weft yarns from the middle to two sides in sequence, the weaving length of each weft yarn is 2-10 mm, and the weft yarns are interwoven by nanofiber yarns in the warp direction and the weft direction.
(3) After weaving is finished, the prepared ribbon-shaped integrated scaffold is subjected to ultrasonic cleaning and freeze drying, and then ethylene oxide sterilization treatment is carried out for 24 hours, so that the integrated scaffold simulating mineralization of bone-tendon-bone to a non-mineralized gradient structure is finally obtained, and the integrated scaffold can be used for artificial tendon/ligament.
The integrated scaffold object with the bone-tendon-bone mineralization-non-mineralization gradient structure obtained in the embodiment 2 is shown in fig. 2, the scaffold is formed by interweaving nanofiber yarns in the warp direction and the weft direction, the processing is relatively simple, and the length, the width, and the size of the mineralized part and the non-mineralized part of the scaffold can be adjusted according to actual requirements.
The surface scanning electron microscope (a) and the transmission electron microscope (b) loaded with the hydroxyapatite nanofibers with different contents obtained in the above example 2 are shown in fig. 4, the diameter of the nanofiber yarn is 200-300 μm, the diameter of a single fiber is 500-800nm, and the pore diameter of the scaffold is 40-70 μm. The surface of the yarn without HA was free of HA deposition, and TEM showed no HA inside the single nanofiber; with the increase of HA in the spinning solution, the deposition of HA on the surface of the yarn is increased, and the HA inside the nanofiber gradually becomes more, which shows that HA is not only deposited on the surface of the fiber, but also successfully electrospun into the inside of the nanofiber.
Scanning electron microscopy of the non-mineralized portion (PPS-0% HA) and the gradient mineralized portion (PPS-5% HA, PPS-10% HA, PPS-15% HA) of the integrated scaffold obtained in example 2 is shown in FIG. 5, and the scaffold HAs a three-dimensional woven structure, which facilitates cell growth into the interior of the scaffold and can simulate the fibrous structure of extracellular matrix of tendon tissue.
The water contact angles of the surfaces of the parts of the integrated scaffold obtained in the above example 2 were measured by using a contact angle meter (DSA 100). separately, part of the water of the scaffold was placed on the stage of the contact angle meter, the size of the distilled water droplet was adjusted (diameter 5 μ L), the distilled water droplet was dropped on the flat surface of the scaffold, and the contact angle was measured and the data was recorded within 5 seconds after dropping the water.
The proliferation activity of the integrated scaffold on BMSC cells is tested by adopting a CCK-8 method, each part of the scaffold is cut into a round piece with the diameter of 14mm, and the round piece is placed in a hole of a 24-hole cell culture plate after being fumigated by alcohol and subjected to ultraviolet sterilization. 2.5 million BMSC cells are planted in each well and put into a carbon dioxide incubator for culture, and the absorbance value of each well is measured at 450nm by using a CCK-8 reagent on days 1, 4 and 7 respectively. As shown in FIG. 7, the OD values of the groups were significantly increased from day 1 to day 7, and the OD values of the PPS-0% HA group at day 7 were significantly higher than those of PPS-5% HA, PPS-10% HA and PPS-15% HA. The scaffold has no obvious cytotoxicity, good cell proliferation condition and good cell compatibility; meanwhile, the addition of hydroxyapatite has certain influence on the cell proliferation rate.
And (3) detecting the bone differentiation capacity of each part of the integrated scaffold for inducing BMSC cells by using an alizarin red quantitative detection kit, cutting each part of the scaffold into round pieces with the diameter of 14mm, fumigating and ultraviolet sterilizing by using alcohol, and placing the round pieces into holes of 24-hole cell culture plates. 2.5 ten thousand BMSC cells are planted in each hole and put into a carbon dioxide incubator for culture, and the absorbance value of each hole is measured at 562nm by using an alizarin red quantitative detection kit on the 21 st day. As shown in FIG. 8, the OD values of the PPS-5% HA, PPS-10% HA, and PPS-15% HA groups were significantly higher than those of the PPS-0% HA group at 21 days, and the OD values gradually increased as the HA content increased. The integrated bracket mineralized part is shown to have the function of promoting the differentiation of stem cells and bones, and the bracket has the potential of guiding the regeneration of tendon tissues and promoting the healing of tendon and bones after being implanted.
Claims (10)
1. The integrated support comprises warps and wefts and is characterized in that the warps are nanofiber yarns with zero mineral content, the wefts in the middle of the support are nanofiber yarns with zero mineral content, and the wefts in the middle of the support are sequentially nanofiber yarns with gradually increased mineral content.
2. The stent of claim 1, wherein the mineral-content zero nanofiber yarn and the mineral-loaded nanofiber yarn are of a core-spun structure, wherein the core layer is a polymer thread and the outer layer is an electrospun nanofiber.
3. The stent of claim 2, wherein the polymer thread is one or more of polyethylene terephthalate (PET) thread, polylactic acid (P L A) thread, polycaprolactone (PC L) thread, lactic acid-glycolic acid copolymer (P L GA) thread and Silk Fibroin (SF) thread, the electrospun nanofiber on the outer layer of the nanofiber yarn with zero mineral content contains electrospun nanofibers of polymer and natural macromolecules but does not contain minerals, and the electrospun nanofiber on the outer layer of the nanofiber yarn with mineral loading contains electrospun nanofibers of mineral, polymer and natural macromolecules.
4. The stent of claim 3, wherein the polymer is one or more of lactic acid-caprolactone copolymer P L C L, polycaprolactone PC L and lactic acid-glycolic acid copolymer P L GA, the natural polymer is one or more of silk fibroin SF, collagen (CO L) and gelatin, and the mineral is one or more of hydroxyapatite HA, bioactive glass, silicon dioxide, calcium carbonate and calcium phosphate mineral.
5. The stent of claim 1 wherein the stent has an appearance of one of an elongated strip, a flat, a cylinder; the length of the support is 5-50 mm, and the width is 5-20 mm.
6. The stent of claim 1, wherein the stent is: the nanofiber yarn with zero mineral content is used as warp yarns, the distance between the two warp yarns is 0.5-2 mm, and 10 warp yarns are adopted for each support; the middle of the bracket uses nanofiber yarns with zero mineral content as wefts, the nanofiber yarns with gradually increased mineral content are sequentially used as wefts from the middle to two sides, the weaving length of each weft is 2-10 mm, and the nanofiber yarns in the warp direction and the weft direction are interwoven to form the bracket.
7. A method of making an integrated stent, comprising:
(1) respectively preparing polymer-containing and natural polymer blending spinning solutions; the blended spinning solution contains polymers, natural polymers and minerals with different contents;
(2) passing a core layer line through a hollow rotating funnel, then connecting the blended spinning solution obtained in the step (1) to two opposite-spraying spinning heads, respectively applying positive and negative electric fields to the spraying spinning heads, spraying the nanofibers on the middle rotating funnel and the core layer line, twisting the nanofibers to the core layer line by the rotating funnel, and receiving by a receiving roller to obtain nanofiber yarns with zero mineral content and nanofiber yarns loaded with minerals with different content;
(3) the mineral content of the nanofiber yarns is zero, the mineral content of the nanofiber yarns is different, the nanofiber yarns in the warp direction and the weft direction are interwoven by a weaving method, the mineral content of the nanofiber yarns is zero in the weft of the middle of the bracket, the mineral content of the nanofiber yarns gradually increasing from the middle to the two ends of the bracket is sequentially adopted as the weft, and the integrated bracket with the mineralized to non-mineralized gradient structure is obtained.
8. The preparation method according to claim 7, wherein the mass ratio of the polymer to the natural polymer in the step (1) is 90: 10-10: 90; the mass fraction of the added minerals in the blended spinning solution is 0-20%.
9. An integrated stent made by the method of claim 7.
10. Use of the integrated scaffold of claim 1 as a tendon or ligament scaffold.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010144383.5A CN111450316B (en) | 2020-03-04 | 2020-03-04 | Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010144383.5A CN111450316B (en) | 2020-03-04 | 2020-03-04 | Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111450316A true CN111450316A (en) | 2020-07-28 |
CN111450316B CN111450316B (en) | 2021-07-20 |
Family
ID=71670627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010144383.5A Active CN111450316B (en) | 2020-03-04 | 2020-03-04 | Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111450316B (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112245661A (en) * | 2020-10-23 | 2021-01-22 | 湖南大学 | TBJ tissue repair film type stent and preparation method thereof |
CN113244451A (en) * | 2021-06-02 | 2021-08-13 | 青岛大学 | Patch material simulating natural tendon-bone gradient interface and preparation method thereof |
CN113388950A (en) * | 2021-06-15 | 2021-09-14 | 青岛大学 | Absorbable high-performance nanofiber woven tendon patch and preparation method thereof |
TWI765500B (en) * | 2020-12-29 | 2022-05-21 | 財團法人工業技術研究院 | Tissue scaffold for use in tendon and/or ligament |
CN114681123A (en) * | 2020-12-29 | 2022-07-01 | 财团法人工业技术研究院 | Tissue scaffold for tendons and/or ligaments |
EP4023265A1 (en) * | 2020-12-29 | 2022-07-06 | Industrial Technology Research Institute | Tissue scaffold for use in tendon and/or ligament |
CN114949353A (en) * | 2022-01-24 | 2022-08-30 | 东华大学 | Biological function differentiated adaptation musculoskeletal system prosthesis and preparation method thereof |
CN115068687A (en) * | 2022-07-08 | 2022-09-20 | 重庆科技学院 | Gradient nano/microfiber scaffold and preparation method and application thereof |
CN115944776A (en) * | 2022-12-30 | 2023-04-11 | 中国科学院上海硅酸盐研究所 | Bio-printing tendon-bone-imitating multi-cell scaffold and preparation method and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102871774A (en) * | 2012-10-15 | 2013-01-16 | 四川大学华西医院 | Ligament repair stent and preparation method and application thereof |
CA2826771A1 (en) * | 2012-09-13 | 2014-03-13 | The Uab Research Foundation | Biomimetic tissue graft for ligament replacement |
CN107596442A (en) * | 2017-10-31 | 2018-01-19 | 上海纳米技术及应用国家工程研究中心有限公司 | The preparation method of gradient biological coating on PET material surface and products thereof and application |
CN107898535A (en) * | 2017-11-17 | 2018-04-13 | 上海利格泰生物科技有限公司 | It is spaced cured artificial ligament |
CN109621011A (en) * | 2018-11-28 | 2019-04-16 | 上海白衣缘生物工程有限公司 | A kind of tendon Biological Repair mesh sheet and application thereof and preparation method |
CN110331486A (en) * | 2019-07-25 | 2019-10-15 | 东华大学 | A kind of multilayered structure nano-fibre yams knitting tendon scaffold and its preparation and application |
CN110693629A (en) * | 2019-11-19 | 2020-01-17 | 上海市第六人民医院 | Sectional and gradient functional tendon sleeve implantation instrument and preparation method thereof |
-
2020
- 2020-03-04 CN CN202010144383.5A patent/CN111450316B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2826771A1 (en) * | 2012-09-13 | 2014-03-13 | The Uab Research Foundation | Biomimetic tissue graft for ligament replacement |
CN102871774A (en) * | 2012-10-15 | 2013-01-16 | 四川大学华西医院 | Ligament repair stent and preparation method and application thereof |
CN107596442A (en) * | 2017-10-31 | 2018-01-19 | 上海纳米技术及应用国家工程研究中心有限公司 | The preparation method of gradient biological coating on PET material surface and products thereof and application |
CN107898535A (en) * | 2017-11-17 | 2018-04-13 | 上海利格泰生物科技有限公司 | It is spaced cured artificial ligament |
CN109621011A (en) * | 2018-11-28 | 2019-04-16 | 上海白衣缘生物工程有限公司 | A kind of tendon Biological Repair mesh sheet and application thereof and preparation method |
CN110331486A (en) * | 2019-07-25 | 2019-10-15 | 东华大学 | A kind of multilayered structure nano-fibre yams knitting tendon scaffold and its preparation and application |
CN110693629A (en) * | 2019-11-19 | 2020-01-17 | 上海市第六人民医院 | Sectional and gradient functional tendon sleeve implantation instrument and preparation method thereof |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112245661B (en) * | 2020-10-23 | 2021-09-10 | 湖南大学 | TBJ tissue repair film type stent and preparation method thereof |
CN112245661A (en) * | 2020-10-23 | 2021-01-22 | 湖南大学 | TBJ tissue repair film type stent and preparation method thereof |
JP7293308B2 (en) | 2020-12-29 | 2023-06-19 | 財團法人工業技術研究院 | Tissue scaffold for tendon and/or ligament use |
TWI765500B (en) * | 2020-12-29 | 2022-05-21 | 財團法人工業技術研究院 | Tissue scaffold for use in tendon and/or ligament |
CN114681123A (en) * | 2020-12-29 | 2022-07-01 | 财团法人工业技术研究院 | Tissue scaffold for tendons and/or ligaments |
EP4023265A1 (en) * | 2020-12-29 | 2022-07-06 | Industrial Technology Research Institute | Tissue scaffold for use in tendon and/or ligament |
JP2022104790A (en) * | 2020-12-29 | 2022-07-11 | 財團法人工業技術研究院 | Tissue scaffold for use in tendon and/or ligament |
CN113244451A (en) * | 2021-06-02 | 2021-08-13 | 青岛大学 | Patch material simulating natural tendon-bone gradient interface and preparation method thereof |
CN113244451B (en) * | 2021-06-02 | 2022-06-03 | 青岛大学 | Patch material simulating natural tendon-bone gradient interface and preparation method thereof |
CN113388950A (en) * | 2021-06-15 | 2021-09-14 | 青岛大学 | Absorbable high-performance nanofiber woven tendon patch and preparation method thereof |
CN114949353A (en) * | 2022-01-24 | 2022-08-30 | 东华大学 | Biological function differentiated adaptation musculoskeletal system prosthesis and preparation method thereof |
CN115068687A (en) * | 2022-07-08 | 2022-09-20 | 重庆科技学院 | Gradient nano/microfiber scaffold and preparation method and application thereof |
CN115068687B (en) * | 2022-07-08 | 2023-12-12 | 重庆科技学院 | Gradient nano/micro fiber support and preparation method and application thereof |
CN115944776A (en) * | 2022-12-30 | 2023-04-11 | 中国科学院上海硅酸盐研究所 | Bio-printing tendon-bone-imitating multi-cell scaffold and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN111450316B (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111450316B (en) | Integrated bracket for simulating bone-tendon-bone mineralization-non-mineralization gradient structure | |
Wu et al. | State-of-the-art review of advanced electrospun nanofiber yarn-based textiles for biomedical applications | |
US12043922B2 (en) | Immersed rotary jet spinning (iRJS) devices and uses thereof | |
US20240131218A1 (en) | Electrospun biocompatible fiber compositions | |
Shao et al. | A biomimetic multilayer nanofiber fabric fabricated by electrospinning and textile technology from polylactic acid and Tussah silk fibroin as a scaffold for bone tissue engineering | |
EP3351376B1 (en) | Silk biomaterials and methods of use thereof | |
US9421305B2 (en) | Aligned scaffolding system for skeletal muscle regeneration | |
EP2373354B1 (en) | Tissue repair scaffold | |
US20130312638A1 (en) | Systems, devices and methods for the fabrication of polymeric fibers | |
CN110331486A (en) | A kind of multilayered structure nano-fibre yams knitting tendon scaffold and its preparation and application | |
CN112553785B (en) | Double-layer guided tissue regeneration membrane and preparation method thereof | |
Reverchon et al. | Biodegradable synthetic scaffolds for tendon regeneration | |
CN104414773A (en) | Anti-adhesion tissue repair membrane and preparation method thereof | |
Liu et al. | Electrospun fibrous silk fibroin/poly (L-lactic acid) scaffold for cartilage tissue engineering | |
CN101653624A (en) | Preparation method of composite nanometer fiber small-diameter intravascular tissue engineering stent material | |
CN107496060A (en) | A kind of three-dimensional artificial total spinal disc and its preparation method and application | |
Wang et al. | Electrospun, reinforcing network-containing, silk fibroin-based nerve guidance conduits for peripheral nerve repair | |
Lee et al. | Biocomposites electrospun with poly (ε-caprolactone) and silk fibroin powder for biomedical applications | |
CN113388950A (en) | Absorbable high-performance nanofiber woven tendon patch and preparation method thereof | |
Hernández-Rangel et al. | Electrospun chitosan materials and their potential use as scaffolds for bone and cartilage tissue engineering | |
CN114504680B (en) | Bone-ligament-bone integrated bracket and preparation method thereof | |
Moy et al. | Fibrous scaffolds for bone tissue engineering | |
Xie et al. | Electrospun polycaprolactone/silk fibroin nanofiber scaffold with aligned fiber orientation for articular chondrocyte regeneration | |
Bosworth et al. | Biocompatible three-dimensional scaffolds for tendon tissue engineering using electrospinning | |
US20230002935A1 (en) | Electrospinning collector for the production of three-dimensional electrospun constructs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210624 Address after: No 9 workshop zhijunpingshan Pharmaceutical Industrial Park Sinopharm Group north of Lanzhu East Road biomedical base Kengzi street Pingshan District Shenzhen City Guangdong Province Applicant after: Shenzhen Meijie Life Science Co.,Ltd. Address before: 201620 No. 2999 North Renmin Road, Songjiang new town, Songjiang District, Shanghai. Applicant before: DONGHUA University |
|
GR01 | Patent grant | ||
GR01 | Patent grant |